Methodological framework for radiomics applications in Hodgkin’s lymphoma
Abstract Background According to published data, radiomics features differ between lesions of refractory/relapsing HL patients from those of long-term responders. However, several methodological aspects have not been elucidated yet. Purpose The study aimed at setting up a methodological framework in...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-06-01
|
Series: | European Journal of Hybrid Imaging |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41824-020-00078-8 |
id |
doaj-edf9cc25ea0b4a40bd3229adfb6810c5 |
---|---|
record_format |
Article |
spelling |
doaj-edf9cc25ea0b4a40bd3229adfb6810c52020-11-25T02:48:16ZengSpringerOpenEuropean Journal of Hybrid Imaging2510-36362020-06-014111710.1186/s41824-020-00078-8Methodological framework for radiomics applications in Hodgkin’s lymphomaMartina Sollini0Margarita Kirienko1Lara Cavinato2Francesca Ricci3Matteo Biroli4Francesca Ieva5Letizia Calderoni6Elena Tabacchi7Cristina Nanni8Pier Luigi Zinzani9Stefano Fanti10Anna Guidetti11Alessandra Alessi12Paolo Corradini13Ettore Seregni14Carmelo Carlo-Stella15Arturo Chiti16Humanitas UniversityHumanitas UniversityHumanitas Clinical and Research CenterHumanitas Clinical and Research CenterHumanitas UniversityMOX–Modelling and Scientific Computing lab., Department of Mathematics, Politecnico di MilanoNuclear Medicine, AOU S.Orsola-MalpighiNuclear Medicine, AOU S.Orsola-MalpighiNuclear Medicine, AOU S.Orsola-MalpighiInstitute of Hematology “Seràgnoli”, University of BolognaNuclear Medicine, AOU S.Orsola-MalpighiFondazione IRCCS Istituto Nazionale dei TumoriFondazione IRCCS Istituto Nazionale dei TumoriFondazione IRCCS Istituto Nazionale dei TumoriFondazione IRCCS Istituto Nazionale dei TumoriHumanitas UniversityHumanitas UniversityAbstract Background According to published data, radiomics features differ between lesions of refractory/relapsing HL patients from those of long-term responders. However, several methodological aspects have not been elucidated yet. Purpose The study aimed at setting up a methodological framework in radiomics applications in Hodgkin’s lymphoma (HL), especially at (a) developing a novel feature selection approach, (b) evaluating radiomic intra-patient lesions’ similarity, and (c) classifying relapsing refractory (R/R) vs non-(R/R) patients. Methods We retrospectively included 85 patients (male:female = 52:33; median age 35 years, range 19–74). LIFEx ( www.lifexsoft.org ) was used for [18F]FDG-PET/CT segmentation and feature extraction. Features were a-priori selected if they were highly correlated or uncorrelated to the volume. Principal component analysis-transformed features were used to build the fingerprints that were tested to assess lesions’ similarity, using the silhouette. For intra-patient similarity analysis, we used patients having multiple lesions only. To classify patients as non-R/R and R/R, the fingerprint considering one single lesion (fingerprint_One) and all lesions (fingerprint_All) was tested using Random Undersampling Boosting of Tree Ensemble (RUBTE). Results HL fingerprints included up to 15 features. Intra-patient lesion similarity analysis resulted in mean/median silhouette values below 0.5 (low similarity especially in the non-R/R group). In the test set, the fingerprint_One classification accuracy was 62% (78% sensitivity and 53% specificity); the classification by RUBTE using fingerprint_All resulted in 82% accuracy (70% sensitivity and 88% specificity). Conclusions Lesion similarity analysis was developed, and it allowed to demonstrate that HL lesions were not homogeneous within patients in terms of radiomics signature. Therefore, a random target lesion selection should not be adopted for radiomics applications. Moreover, the classifier to predict R/R vs non-R/R performed the best when all the lesions were used.http://link.springer.com/article/10.1186/s41824-020-00078-8LymphomaPET/CTRadiomicsSimilarityFeature selectionSilhouette |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Martina Sollini Margarita Kirienko Lara Cavinato Francesca Ricci Matteo Biroli Francesca Ieva Letizia Calderoni Elena Tabacchi Cristina Nanni Pier Luigi Zinzani Stefano Fanti Anna Guidetti Alessandra Alessi Paolo Corradini Ettore Seregni Carmelo Carlo-Stella Arturo Chiti |
spellingShingle |
Martina Sollini Margarita Kirienko Lara Cavinato Francesca Ricci Matteo Biroli Francesca Ieva Letizia Calderoni Elena Tabacchi Cristina Nanni Pier Luigi Zinzani Stefano Fanti Anna Guidetti Alessandra Alessi Paolo Corradini Ettore Seregni Carmelo Carlo-Stella Arturo Chiti Methodological framework for radiomics applications in Hodgkin’s lymphoma European Journal of Hybrid Imaging Lymphoma PET/CT Radiomics Similarity Feature selection Silhouette |
author_facet |
Martina Sollini Margarita Kirienko Lara Cavinato Francesca Ricci Matteo Biroli Francesca Ieva Letizia Calderoni Elena Tabacchi Cristina Nanni Pier Luigi Zinzani Stefano Fanti Anna Guidetti Alessandra Alessi Paolo Corradini Ettore Seregni Carmelo Carlo-Stella Arturo Chiti |
author_sort |
Martina Sollini |
title |
Methodological framework for radiomics applications in Hodgkin’s lymphoma |
title_short |
Methodological framework for radiomics applications in Hodgkin’s lymphoma |
title_full |
Methodological framework for radiomics applications in Hodgkin’s lymphoma |
title_fullStr |
Methodological framework for radiomics applications in Hodgkin’s lymphoma |
title_full_unstemmed |
Methodological framework for radiomics applications in Hodgkin’s lymphoma |
title_sort |
methodological framework for radiomics applications in hodgkin’s lymphoma |
publisher |
SpringerOpen |
series |
European Journal of Hybrid Imaging |
issn |
2510-3636 |
publishDate |
2020-06-01 |
description |
Abstract Background According to published data, radiomics features differ between lesions of refractory/relapsing HL patients from those of long-term responders. However, several methodological aspects have not been elucidated yet. Purpose The study aimed at setting up a methodological framework in radiomics applications in Hodgkin’s lymphoma (HL), especially at (a) developing a novel feature selection approach, (b) evaluating radiomic intra-patient lesions’ similarity, and (c) classifying relapsing refractory (R/R) vs non-(R/R) patients. Methods We retrospectively included 85 patients (male:female = 52:33; median age 35 years, range 19–74). LIFEx ( www.lifexsoft.org ) was used for [18F]FDG-PET/CT segmentation and feature extraction. Features were a-priori selected if they were highly correlated or uncorrelated to the volume. Principal component analysis-transformed features were used to build the fingerprints that were tested to assess lesions’ similarity, using the silhouette. For intra-patient similarity analysis, we used patients having multiple lesions only. To classify patients as non-R/R and R/R, the fingerprint considering one single lesion (fingerprint_One) and all lesions (fingerprint_All) was tested using Random Undersampling Boosting of Tree Ensemble (RUBTE). Results HL fingerprints included up to 15 features. Intra-patient lesion similarity analysis resulted in mean/median silhouette values below 0.5 (low similarity especially in the non-R/R group). In the test set, the fingerprint_One classification accuracy was 62% (78% sensitivity and 53% specificity); the classification by RUBTE using fingerprint_All resulted in 82% accuracy (70% sensitivity and 88% specificity). Conclusions Lesion similarity analysis was developed, and it allowed to demonstrate that HL lesions were not homogeneous within patients in terms of radiomics signature. Therefore, a random target lesion selection should not be adopted for radiomics applications. Moreover, the classifier to predict R/R vs non-R/R performed the best when all the lesions were used. |
topic |
Lymphoma PET/CT Radiomics Similarity Feature selection Silhouette |
url |
http://link.springer.com/article/10.1186/s41824-020-00078-8 |
work_keys_str_mv |
AT martinasollini methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT margaritakirienko methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT laracavinato methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT francescaricci methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT matteobiroli methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT francescaieva methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT letiziacalderoni methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT elenatabacchi methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT cristinananni methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT pierluigizinzani methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT stefanofanti methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT annaguidetti methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT alessandraalessi methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT paolocorradini methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT ettoreseregni methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT carmelocarlostella methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma AT arturochiti methodologicalframeworkforradiomicsapplicationsinhodgkinslymphoma |
_version_ |
1724748763856109568 |